AtriCure (ATRC) Operating Leases (2019 - 2025)
AtriCure (ATRC) has disclosed Operating Leases for 7 consecutive years, with $7.4 million as the latest value for Q1 2025.
- On a quarterly basis, Operating Leases changed N/A to $7.4 million in Q1 2025 year-over-year; TTM through Mar 2025 was $7.4 million, a N/A change, with the full-year FY2024 number at $6.2 million, up 87.42% from a year prior.
- Operating Leases was $7.4 million for Q1 2025 at AtriCure, up from $6.2 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $12.5 million in Q3 2024 to a low of $966000.0 in Q1 2021.
- A 5-year average of $5.4 million and a median of $4.1 million in 2021 define the central range for Operating Leases.
- Peak YoY movement for Operating Leases: tumbled 37.21% in 2022, then soared 294.59% in 2024.
- AtriCure's Operating Leases stood at $4.9 million in 2021, then tumbled by 37.21% to $3.1 million in 2022, then rose by 6.85% to $3.3 million in 2023, then surged by 87.42% to $6.2 million in 2024, then grew by 18.88% to $7.4 million in 2025.
- Per Business Quant, the three most recent readings for ATRC's Operating Leases are $7.4 million (Q1 2025), $6.2 million (Q4 2024), and $12.5 million (Q3 2024).